Gene · 3437
Papers3,172
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,172
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analyses of single-cell transcriptomics identify metastasis-associated myeloid subpopulations in breast cancer lung metastasis. | Front Immunol | 2023 | 37483625 | PubTator, text mining | PubMed |
| Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids. | Immunity | 2023 | 37478854 | PubTator, text mining | PubMed |
| Evaluation of lncRNA Expression Pattern and Potential Role in Heart Failure Pathology. | Dis Markers | 2023 | 37476628 | PubTator, text mining | PubMed |
| Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector. | Nat Commun | 2023 | 37474509 | PubTator, text mining | PubMed |
| Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection. | Emerg Microbes Infect | 2023 | 37470396 | PubTator, text mining | PubMed |
| Defining the role of natural killer cells in COVID-19. | Nat Immunol | 2023 | 37460639 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses. | iScience | 2023 | 37456846 | PubTator, text mining | PubMed |
| Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer. | Cell Rep Med | 2023 | 37451269 | PubTator, text mining | PubMed |
| Calpeptin may reverse glucocorticoid-resistance of allergic rhinitis associated with cigarette smoke exposure by down-regulating interferon regulatory factor 1. | Heliyon | 2023 | 37449098 | PubTator, text mining | PubMed |
| S-Nitrosylation of Tissue Transglutaminase in Modulating Glycolysis, Oxidative Stress, and Inflammatory Responses in Normal and Indoxyl-Sulfate-Induced Endothelial Cells. | Int J Mol Sci | 2023 | 37446114 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals the Inability of Recombinant AAV8 to Activate Human Monocyte-Derived Dendritic Cells. | Int J Mol Sci | 2023 | 37445621 | PubTator, text mining | PubMed |
| Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions. | Cancers (Basel) | 2023 | 37444436 | PubTator, text mining | PubMed |
| EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. | Mol Metab | 2023 | 37442376 | PubTator, text mining | PubMed |
| Mechanisms of circovirus immunosuppression and pathogenesis with a focus on porcine circovirus 2: a review. | Vet Q | 2023 | 37431709 | PubTator, text mining | PubMed |
| A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer. | BMC Genomics | 2023 | 37430202 | PubTator, text mining | PubMed |
| Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles. | PLoS Pathog | 2023 | 37428812 | PubTator, text mining | PubMed |
| Advanced methods and novel biomarkers in autoimmune diseases ‑ a review of the recent years progress in systemic lupus erythematosus. | Front Med (Lausanne) | 2023 | 37425332 | PubTator, text mining | PubMed |
| Gene expression of peripheral blood mononuclear cells and CD8+ T cells from gilts after PRRSV infection. | Front Immunol | 2023 | 37409113 | PubTator, text mining | PubMed |
| BRI2-mediated regulation of TREM2 processing in microglia and its potential implications for Alzheimer's disease and related dementias. | bioRxiv | 2023 | 37398330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3437/papers?page=20